Aamal Company Q.P.S.C. through its Subsidiary Ebn Sina Medical, announces its intention to Commence Negotiations for Potential Acquisition
Doha, Qatar – 08 June 2026: Aamal Company Q.P.S.C. ("Aamal"), one of the region's leading diversified companies, announces its intention to commence negotiations, through its subsidiary, Ebn Sina Medical, in relation to a potential acquisition as part of Aamal's strategy to expand and further diversify its business portfolio.
Aamal's subsidiary, Ebn Sina Medical, intends to commence negotiations to acquire shares in "Q life Pharma" (Qatar Llhayat Factory W.L.L.), specializing in the manufacture of bags and bottles for medical and sterile intravenous solutions, as well as a range of pharmaceutical products, including tablets, capsules, dry suspensions, syrups, liquid suspensions, ointments, creams, eye drops, suppositories, injectable solutions, and antibiotics.
This potential acquisition is aligned with Aamal's strategic objectives of expanding and diversifying its operations, while supporting the objectives of Qatar National Vision 2030.
The proposed transaction remains subject to ongoing negotiations, the execution of definitive agreement, regulatory approvals, and other customary conditions. Aamal will make further disclosures as appropriate and in accordance with applicable regulatory requirements.
– End –
FURTHER ENQUIRIES
Aamal Company [email protected]
ABOUT AAMAL COMPANY Q.P.S.C.
Aamal is one of the Gulf region's most diversified conglomerates and has been listed on the Qatar Stock Exchange since December 2007. As of 8 June 2026, the Company had market capitalisation of QAR 4.6bn (US $1.3 bn).
Aamal's operations are widely diversified and comprise 32 active business units (subsidiaries and joint ventures) with market leading positions in the key industrial, retail, property, managed services, and medical equipment and pharmaceutical sectors, thereby offering investors a high quality and balanced exposure to Qatar's wider economic growth and development.
For further information on Aamal Company, please refer to the corporate website: http://www.aamal.qa
About QLife Pharma
QLife Pharma (Qatar Life FACTORY) is one of Qatar's leading national pharmaceutical manufacturers. Established in 2011, the company operates in accordance with the highest international pharmaceutical manufacturing and quality standards (cGMP). The facility spans approximately 13,000 m² and includes modern research and development, manufacturing, and quality control units. QLife Pharma produces a wide range of pharmaceutical products, including tablets, capsules, oral liquids, creams, ointments, and gels. The company supplies healthcare institutions in both the public and private sectors within Qatar and internationally, contributing to pharmaceutical security and strengthening the national pharmaceutical industry.
